Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Tenax Therapeutics (TENX) Assets Average (2016 - 2026)

Tenax Therapeutics' Assets Average history spans 5 years, with the latest figure at $10.4 million for Q4 2017.

  • On a quarterly basis, Assets Average fell 74.84% to $10.4 million in Q4 2017 year-over-year; TTM through Dec 2017 was $10.4 million, a 74.84% decrease, with the full-year FY2017 number at $16.6 million, down 65.5% from a year prior.
  • Assets Average hit $10.4 million in Q4 2017 for Tenax Therapeutics, down from $12.2 million in the prior quarter.
  • Over the last five years, Assets Average for TENX hit a ceiling of $61.9 million in Q3 2016 and a floor of $3.1 million in Q2 2013.
  • Historically, Assets Average has averaged $21.3 million across 3 years, with a median of $14.3 million in 2017.
  • Biggest five-year swings in Assets Average: tumbled 36.92% in 2013 and later tumbled 80.26% in 2017.
  • Tracing TENX's Assets Average over 3 years: stood at $3.1 million in 2013, then skyrocketed by 1234.5% to $41.5 million in 2016, then plummeted by 74.84% to $10.4 million in 2017.
  • Business Quant data shows Assets Average for TENX at $10.4 million in Q4 2017, $12.2 million in Q3 2017, and $16.3 million in Q2 2017.